Abstract
Rare genetic disorders are a group of diseases that are caused by changes in a person’s genes. These changes can be inherited from parents or occur spontaneously. Rare genetic disorders can affect any part of the body, and they can range in severity from mild to life-threatening. There are over 7000 rare genetic disorders that have been identified, and many more are still being discovered. These disorders affect an estimated 30 million people in the United States alone. The diagnosis of a rare genetic disorder can be challenging, as the symptoms can be varied and often nonspecific. However, there are a number of genetic tests that can be used to diagnose these disorders. There is no one-size-fits-all treatment for rare genetic disorders. The treatment plan will vary depending on the specific disorder and the individual’s symptoms. However, there are a number of treatments that can help improve the quality of life for people with these disorders. Research into rare genetic disorders is ongoing, and there is hope that new treatments will be developed in the future. In the meantime, there are a number of resources available to help people with rare genetic disorders and their families. This book chapter provides a brief overview of rare genetic disorders, including their causes, symptoms, diagnosis, treatment, and research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Allen JN, Magro CM, King MA (2002) The eosinophilic pneumonias. Semin Respir Crit Care Med 23:127–134. http://www.ncbi.nlm.nih.gov/pubmed/16088605
Al-Mutairi N, Al-Shaikh A, Nampoothiri N (2016) 17β-Hydroxysteroid dehydrogenase type 10 deficiency presenting as male pseudohermaphroditism. Saudi Med J 37(5):573–576
Al-Saud B, Al-Mousa H (1993–2022) ARPC1B deficiency. 2021 Sep 28. In: Adam MP, Ardinger HH, Pagon RA, et al. (eds) GeneReviews®. University of Washington, Seattle, WA. Available from: https://www.ncbi.nlm.nih.gov/books/NBK518710/
Al-Semari A, Wakil SM, Al-Muhaizea MA et al (2013) Novel FGD1 variant underlying Aarskog-Scott syndrome with myopathy and distal arthropathy. Clin Dysmorphol 22:13–17
Alston CL, Rocha MC, Lax NZ, Turnbull DM, Taylor RW (2017) The genetics and pathology of mitochondrial disease. J Pathol 241(2):236–250. https://doi.org/10.1002/path.4809. Epub 2016 Nov 22
Al-Tubaikh JA, Reiser MF (2009) Encephalocele. In: Congenital diseases and syndromes—an illustrated radiological guide. Springer-Verlag, Berlin, Heidelberg, pp 3–4
Al-Yahyaee SA, Al-Kindi MN, Habbal O, Kumar DS (2003) Clinical and molecular analysis of Grebe acromesomelic dysplasia in an Omani family. Am J Med Genet A 121:9–14
Arkkila PE (2006) Thromboangiitis obliterans (Buerger’s disease). Orphanet J Rare Dis 1(1):1–5
Auchus RJ (2017) The genetics, pathophysiology, and management of human deficiencies of P450c17. Endocrinol Metab Clin 46(2):375–393
Bartels CF, Bukulmez H, Padayatti P et al (2004) Mutations in the transmembrane natriuretic peptide receptor NPR-B impair skeletal growth and cause acromesomelic dysplasia type Maroteaux. Am J Hum Genet 75:27–34
Beers MH, Berkow R (eds) (1999) The Merck manual, 17th edn. Merck Research Laboratories, Whitehouse Station, NJ, p 973
Beers MH, Porter RS, Jones TV (2006) The Merck manual of diagnosis and therapy. Merck Research Laboratories, Whitehouse Station, NJ
Behrman RE, Kliegman RM, Arvin AM (eds) (1996) Nelson textbook of pediatrics, 15th edn. W.B. Saunder Company, Philadelphia, PA, p 1439
Bergfeld WF, Elston DM (2003) Cicatricial Alopecia. In: Olsen EA (ed) Disorders of hair growth: diagnosis and treatment. McGraw-Hill, New York, NY
Bigley V, Maisuria S, Cytlak U, Jardine L, Care MA, Green K, Gunawan M, Milne P, Dickinson R, Harrison RE, Haniffa M, Collin M (2018) Biallelic interferon regulatory factor 8 mutation: a complex immunodeficiency syndrome with dendritic cell deficiency, monocytopenia, and immune dysregulation. J Allergy Clin Immunol 141(6):2234–2248
Blackwell KE, Rawnsley JD (2008) Aesthetic considerations in scalp reconstruction. Facial Plast Surg 24(1):11–21
Bonafe L, Cormier-Daire V, Hall C, Lachman R, Mortier G, Mundlos S, Nishimura G, Sangiorgi L, Savarirayan R, Sillence D, Spranger J, Superti-Furga A, Warman M, Unger S (2015) Nosology and classification of genetic skeletal disorders: 2015 revision. Am J Med Genet A 167A:2869–2892
Bottani A, Orrico A, Galli L et al (2007) Unilateral focal polymicrogyria in a patient with classical Aarskog-Scott Syndrome due to a novel missense variant in an evolutionary conserved RhoGEF domain of the faciogenital dysplasia gene FGD1. Am J Med Genet A 143A:2334–2338
Bousfiha A, Jeddane L, Al-Herz W et al (2015) The 2015 IUIS phenotypic classification for primary immunodeficiencies. J Clin Immunol 35(8):727–738. https://doi.org/10.1007/s10875-015-0201-1. Epub 2015 Oct 23
Brady AF, Demirdas S, Fournel-Gigleux S et al (2017) The Ehlers-Danlos syndromes, rare types. Am J Med Genet C Semin Med Genet 175(1):70–115. https://doi.org/10.1002/ajmg.c.31550
Burns SO, Zenner HL, Plagnol V, Curtis J, Mok K, Eisenhut M, Kumararatne D, Doffinger R, Thrasher AJ (2013) Investigation of primary immunodeficiencies in patients with chronic mucocutaneous candidiasis. Immunology 138(3):235–245
Çakır E, Çamtosun F, Gürkan F et al (2019) 17β-Hydroxysteroid dehydrogenase type 10 deficiency: a novel case with a potential homozygous founder mutation. J Pediatr Endocrinol Metab 32(6):661–665
Cartier N, Aubourg P (2018) Gene therapy for X-linked adrenoleukodystrophy. Neurotherapeutics 15(3):587–597
Castanet M, Park SM, Smith A, Bost M, Léger J (2020) Genetics of thyroid dysgenesis: evolving insights. Semin Cell Dev Biol 98:155–162. https://doi.org/10.1016/j.semcdb.2019.11.011. Epub 2019 Nov 20
Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A (2017) A framework for the classification of joint hypermobility and related conditions. Am J Med Genet C Semin Med Genet 175(1):148–157
Cheson BD, Bennett JM, Grever M, Kay N, Keating MJ, O’Brien S, Rai KR (1996) National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. Blood 87(12):4990–4997
Colombi M, Dordoni C, Chiarelli N, Ritelli M (2015) Differential diagnosis and diagnostic flow chart of joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type compared to other heritable connective tissue disorders. Am J Med Genet C Semin Med Genet 169(1):6–22
Cooper GM, Shendure J (2011) Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat Rev Genet 12(9):628–640
De Wals P, Tairou F, Van Allen MI et al (2007) Reduction in neural-tube defects after folic acid fortification in Canada. N Engl J Med 357:135–142. http://www.ncbi.nlm.nih.gov/pubmed/17625125
Döhner H, Stilgenbauer S, Döhner K, Bentz M, Lichter P (1999) Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis. J Mol Med 77:266–281
Eichler FS, Aubourg P (2006) Therapy for X-linked adrenoleukodystrophy. Curr Opin Neurol 19(6):606–610
Engelen M, Kemp S, Poll-The BT, van Geel BM, Wanders RJ, Aubourg P (2012) X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management. Orphanet J Rare Dis 7(1):1–21
Evans NS, Ratchford EV (2014) Vascular disease patient information page: venous thromboembolism (deep vein thrombosis and pulmonary embolism). Vasc Med 19(2):148–150
Finsterer J (2018) Mitochondrial encephalomyopathies. J Neurol Sci 395:4–9. https://doi.org/10.1016/j.jns.2018.10.012. Epub 2018 Oct 10
Forlino A, Marini JC (2016) Osteogenesis imperfecta. Lancet 387:1657–1671
Fujinami K, Zernant J, Chana RK et al (2015) Clinical and molecular characteristics of childhood-onset Usher syndrome. Am J Ophthalmol 159(5):987–996. https://doi.org/10.1016/j.ajo.2015.02.005
Geng R, Geller SF, Hayashi T et al (2009) Usher syndrome IIIA gene clarin-1 is essential for hair cell function and associated neural activation. Hum Mol Genet 18(14):2748–2760. https://doi.org/10.1093/hmg/ddp211
Gorski JL (2003) Aarskog syndrome. In: NORD guide to rare disorders. Lippincott Williams & Wilkins, Philadelphia, PA, p 142
Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27(7):1777–1779. PMID: 10914845
Günther S, Schlaf G, Sticht H, Schwarz K (2020) Transcriptional regulation of MHC class II genes: lessons from a disease. Immunogenetics 72(1–2):1–14. https://doi.org/10.1007/s00251-019-01131-1. Epub 2019 Nov 16
Harakalova M, van der Smagt JJ, de Kovel CGF, Van’t Slot R, Poot M, Nijman I, Houweling AC (2012) Incomplete segregation of MYH11 variants with thoracic aortic aneurysms and dissections and patent ductus arteriosus. Eur J Hum Genet 20(6):581–584
Jeong YJ, Kim KL, Seo IJ et al (2007) Eosinophilic lung diseases: a clinical, radiologic, and pathologic overview. Radiographics 27:617–637. http://www.ncbi.nlm.nih.gov/pubmed/17495282
Jones KL (ed) (1997) Smith’s recognizable patterns of human malformation, 5th edn. W. B. Saunders Co., Philadelphia, PA, pp 128–129
Kahr WHA, Pluthero FG, Elkadri A, Warner N, Drobac M, Chen CH, Lo RW, Li L, Li R, Li Q, Thoeni C, Pan J, Leung G, Lara-Corrales I, Murchie R, Cutz E et al (2017) Loss of the Arp2/3 complex component ARPC1B causes platelet abnormalities and predisposes to inflammatory disease. Nat Commun 8:14816
Kaname T, Yanagi K, Okamoto N, Naritomi K (2006) Neurobehavioral disorders in patients with Aarskog-Scott Syndrome affected by novel FGD1 variants. Am J Med Genet A 140:1331–1332
Kaur S, Smith HS, Mathew S (2018) Cantu syndrome: a rare genetic disorder. J Genet Couns 27(5):1237–1242
Khan S, Basit S, Khan MA, Muhammad N, Ahmad W (2016) Genetics of human isolated acromesomelic dysplasia. Eur J Med Genet 59(4):198–203
Kim YJ, Kim GH, Cheon CK, Cho HJ (2019) Clinical and genetic analysis of 4 Korean patients with congenital adrenal hyperplasia due to 17α-hydroxylase/17, 20-lyase deficiency. Ann Pediatr Endocrinol Metab 24(4):247–252
Kimberling WJ, Hildebrand MS, Shearer AE et al (2010) Frequency of Usher syndrome in two pediatric populations: implications for genetic screening of deaf and hard of hearing children. Genet Med 12(9):512–516. https://doi.org/10.1097/GIM.0b013e3181ec44f8
Kirschner RE, Sutcliffe AJ (2005) The Ehlers-Danlos syndromes. Clin Plast Surg 32(4):627–647. https://doi.org/10.1016/j.cps.2005.05.004
Kornak U, Mundlos S (2003) Genetic disorders of the skeleton: a developmental approach. Am J Hum Genet 73:447–474
Lake NJ, Compton AG, Rahman S, Thorburn DR (2016) Leigh syndrome: One disorder, more than 75 monogenic causes. Ann Neurol 79(2):190–203. https://doi.org/10.1002/ana.24532. Epub 2015 Dec 19
Lebel RR, May M, Pouls S, Lubs HA, Stevenson RE, Schwartz CE (2002) Non-syndromic X-linked mental retardation associated with a missense variant (P312L) in the FGD1 gene. Clin Genet 61:139–145
Lee BH, Kim YM, Kim OH, Choi JH, Yoo WJ, Cho TJ (2012) Update on the molecular pathology of skeletal dysplasias. J Pathol Transl Med 46:561–571
Liu XZ, Angeli S, Liu W et al (2017) Cochlear implantation in individuals with Usher type 1 syndrome. Int J Pediatr Otorhinolaryngol 101:45–50. https://doi.org/10.1016/j.ijporl.2017.08.009
Mahapatra AK (2007) Management of encephaloceles. In: Ramamurthi R, Sridhar K, Vasudevan MC (eds) Textbooks of operative neurosurgery. BI Publications, New Delhi, pp 279–290
Malfait F, Francomano C, Byers P et al (2017) The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 175(1):8–26
Mathur P, Yang J (2015) Usher syndrome: hearing loss, retinal degeneration and associated abnormalities. Biochim Biophys Acta 1852(3):406–420. https://doi.org/10.1016/j.bbadis.2014.05.015
McCormick PA (2003) Banti syndrome. In: NORD guide to rare disorders. Lippincott Williams & Wilkins, Philadelphia, PA, pp 377–378
Mehta A, Sundaram D, Chaudhary S et al (2018) 17β-Hydroxysteroid dehydrogenase type 10 deficiency: a rare cause of hyperandrogenism in females. J Pediatr Adolesc Gynecol 31(3):250–253
Mellstedt H (2007) Clinical signs and symptoms at diagnosis and its differential diagnosis. Ann Oncol 18:i14–i21
Miller BA, Gray A, Leblanc TW et al (2010) Acute eosinophilic pneumonia secondary to daptomycin: a report of three cases. Clin Infect Dis 50:63–68. http://www.ncbi.nlm.nih.gov/pubmed/20420515
Moore CA, Li S, Li Z, Hong SX, Gu HQ, Berry RJ, Mulinare J, Erickson JD (1997) Elevated rates of severe neural tube defects in a high-prevalence area in northern China. Am J Med Genet 73(2):113–118
Moser HW, Raymond GV (2007) X-linked adrenoleukodystrophy. Lancet Neurol 6(11):1044–1055
Muzza M, Rabbiosi S, Vigone MC, Zamproni I, Cirello V, Maffini MA, Bonomi M, Colombo C, Fugazzola L (2014) Congenital hypothyroidism with eutopic thyroid gland: analysis of clinical and biochemical features at diagnosis and after re-evaluation. J Clin Endocrinol Metab 99(12):4333–4340. https://doi.org/10.1210/jc.2014-2349. Epub 2014 Sep 10
Nogueira C, Uziel G, Perez MJ et al (2019) Impaired complex III activity in peripheral blood cells of patients with Parkinson’s disease. Eur Neurol 81(1–2):1–7. https://doi.org/10.1159/000496424. Epub 2019 Jan 9
Ochoa BE, King LE Jr, Price VH (2008) Lichen planopilaris: annual incidence in four hair referral centers in the United States. J Am Acad Dermatol 58(2):352–353
Olney RC, Bukulmez H, Bartels CF, Prickett TC, Espiner EA, Potter LR, Warman ML (2006) Heterozygous mutations in natriuretic peptide receptor-B (NPR2) are associated with short stature. J Clin Endocrinol Metab 91:1229–1232
Olsen EA (2005) Female pattern hair loss and its relationship to permanent/cicatricial alopecia: a new perspective. J Investig Dermatol Symp Proc 10:217–221
Orrico A, Galli L, Cavaliere ML et al (2004) Phenotypic and molecular characterisation of the Aarskog syndrome: a survey of the clinical variability considering FDG1 variant analysis in 46 patients. Eur J Hum Genet 12:16–23
Orrico A, Galli L, Buoni S et al (2005) Attention-deficit/hyperactivity disorder (ADHD) and variable clinical expression of Aarskog-Scott Syndrome due to a novel FGD1 gene variant (R408Q). Am J Med Genet A 135:99–102
Orrico A, Galli L, Obregón MG, de Castro Perez MF, Falciani M, Sorrentino V (2007) Unusually severe expression of craniofacial features in Aarskog-Scott syndrome due to a novel truncating variant of the FDG1 gene. Am J Med Genet A 143:58–63
Orrico A, Galli L, Faivre L et al (2010) Aarskog-Scott syndrome: clinical update and report of nine novel variants of the FGD1 gene. Am J Med Genet A 152A:313–318
Orrico A, Galli L, Clayton-Smith J, Fryns J-P (2015) Clinical utility gene card for: Aarskog–Scott syndrome (faciogenital dysplasia)—update 2015. Eur J Hum Genet 23(4):558. https://doi.org/10.1038/ejhg.2014.178
Park SM, Chatterjee VK (2005) Genetics of congenital hypothyroidism. J Med Genet 42(10):379–389. https://doi.org/10.1136/jmg.2004.024646
Philit F, Etienne-Mastroianni B, Parrot A et al (2002) Idiopathic acute eosinophilic pneumonia. A study of 22 patients. Am J Respir Crit Car Med 166:1235–1239. http://www.ncbi.nlm.nih.gov/pubmed/12403693
Pickhardt PJ, Balfe DM (1998) Portal vein calcification and associated biliary stricture in idiopathic portal hypertension (Banti’s syndrome). Abdom Imaging 23:180–182
Pilozzi-Edmonds L, Maher TA, Basran RK et al (2011) Fraternal twins with Aarskog-Scott Syndrome due to maternal germline mosaicism. Am J Med Genet A 55A:1987–1990
Podhorecka M, Halicka D, Szymczyk A, Macheta A, Chocholska S, Hus M, Darzynkiewicz Z (2016) Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia. Oncotarget 7(22):32846
Poletti V, Costabel U, Casoni GL et al (2004) Rare infiltrative lung diseases: a challenge for clinicians. Respiration 71:431–443. http://www.ncbi.nlm.nih.gov/pubmed/15467318
Potter LR, Abbey-Hosch S, Dickey DM (2006) Natriuretic peptides, their receptors, and cyclic guanosine monophosphate-dependent signaling functions. Endocr Rev 27:47–72
Price V, Mirmirani P (2011) Cicatricial alopecia: an approach to diagnosis and management. Springer, New York Dordrecht Heidelberg London
Ravenna P (1940) Banti syndrome (fibrocongestive splenomegaly): definition, classification and pathogenesis. Arch Intern Med 66(4):879–892
Reith W, LeibundGut-Landmann S, Waldburger JM (2005) Regulation of MHC class II gene expression by the class II transactivator. Nat Rev Immunol 5(1):793–806. https://doi.org/10.1038/nri1707
Rhee CK, Min KH, Yim NY, Lee JE, Lee NR, Chung MP, Jeon K (2013) Clinical characteristics and corticosteroid treatment of acute eosinophilic pneumonia. Eur Respir J 41:402–409. http://www.ncbi.nlm.nih.gov/pubmed/22599359
Rodenburg RJ (2016) Mitochondrial complex I-linked disease. Biochim Biophys Acta 1857(5):938–945. https://doi.org/10.1016/j.bbabio.2016.01.005. Epub 2016 Jan 8
Saito Y, Sasaki KI, Katsuda Y, Murohara T, Takeshita Y, Okazaki T, Arima K, Katsuki Y, Shintani S, Shimada T, Akashi H (2007) Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger’s disease. Circ J 71(8):1187–1192
Satoh M, Yokoya S (2006) Anabolic steroid and gonadotropin releasing hormone analog combined treatment increased pubertal height gain and adult height in two children who entered puberty with short stature. J Pediatr Endocrinol Metab 19:1125–1131
Savarirayan R, White SM, Goodman FR et al (2003) Broad phenotypic spectrum caused by an identical heterozygous CDMP-1 mutation in three unrelated families. Am J Med Genet A 117:136–142
Schmitt TL, Parikh P, Crary SE (2012) Bamforth-Lazarus syndrome: report of a case with a novel mutation in the NKX2-1 gene and review of the literature. Pediatr Dev Pathol 15(4):318–322. https://doi.org/10.2350/11-08-1066-CR.1. Epub 2012 Mar 29
Schwartz CE, Gillessen-Kaesbach G, May M et al (2000) Two novel variants confirm FDG1 is responsible for the Aarskog syndrome. Eur J Hum Genet 8:869–874
Shalev SA, Chervinski E, Weiner E, Mazor G, Friez MJ, Schwartz CE (2006) Clinical variation of Aarskog syndrome in a large family with 2189delA in the FGD1 gene. Am J Med Genet A 140:162–165
Shorr AF, Scoville SL, Cersovsky SB et al (2004) Acute eosinophilic pneumonia among US military personnel deployed in or near Iraq. JAMA 292:2997–3005. http://jama.ama-assn.org/content/292/24/2997.long
Siffel C, Wong LY, Olney RS, Correa A (2003) Survival of infants diagnosed with encephalocele in Atlanta, 1979–98. Paediatr Perinat Epidemiol 17:40–48. http://www.ncbi.nlm.nih.gov/pubmed/12562471
Simon HU, Seger R (2019) ARPC1B deficiency—from bedside to bench and back again. Immunol Rev 287(1):62–72
Stoll C, Dott B, Alembik Y, Roth MP (2011) Associated malformations among infants with neural tube defects. Am J Med Genet A 155A:565–568. http://www.ncbi.nlm.nih.gov/pubmed/21337695
Szczaluba K, Hilbert K, Obersztyn E, Zabel B, Mazurczak T, Kozlowski K (2005) Du Pan syndrome phenotype caused by heterozygous pathogenic mutations in CDMP1 gene. Am J Med Genet A 138(4):379–383
Tsigkaropoulou E, Hatzilia D, Rizos E et al (2011) Venlafaxine-induced acute eosinophilic pneumonia. Gen Hosp Psychiatry 33:e7–e9. http://www.ncbi.nlm.nih.gov/pubmed/21762842
Turcu AF, Auchus RJ, Rainey WE (2015) Adrenal androgens and androgen precursors—defining their role in human physiology and disease. Endocr Rev 36(3):348–373
Verhoeven WM, Egger JI, Hoogeboom AJ (2012) X-linked Aarskog syndrome: report on a novel FGD1 gene variant. Executive dysfunction as part of the behavioural phenotype. Genet Couns 23:157–167
Waqar SN, Jindani S, Baig NS et al (2004) Banti’s syndrome: case report and review of the literature. J Pak Med Assoc 54:99–101
Watts RA, Scott DG (2003) Epidemiology of the vasculitides. Curr Opin Rheumatol 15(1):11–16
Whiting DA (2001) Cicatricial Alopecia: clinico-pathological findings and treatment. Clin Dermatol 19:211–225
Wu H, Chen CL (2019) 17β-Hydroxysteroid dehydrogenase type 10 and its role in human disease. Mol Cell Endocrinol 489:34–42
Wu WY, Otberg N, McElwee KJ, Shapiro J (2008) Diagnosis and management of primary cicatricial Alopecia: Part II. Skinmed 7(2):78–83
Wu F, Ding H, Zhang Z (2012) Antibody-mediated drug delivery system for lymphatic targeting treatment. In: Antibody-mediated drug delivery systems: concepts technology, and applications, pp 169–190. https://doi.org/10.1002/9781118229019.ch9
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Parthasarathy, A., Raju, M., Kulanthaivel, L., Subbaraj, G.K. (2024). Introduction to Rare Genetic Disorders. In: Umair, M., Rafeeq, M., Alam, Q. (eds) Rare Genetic Disorders. Springer, Singapore. https://doi.org/10.1007/978-981-99-9323-9_1
Download citation
DOI: https://doi.org/10.1007/978-981-99-9323-9_1
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-99-9322-2
Online ISBN: 978-981-99-9323-9
eBook Packages: MedicineMedicine (R0)